U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082595) titled 'Personalized Stimulation Loop for Neurorehabilitation in Parkinson: a Proof-of-principle Study' on June 20.
Brief Summary: Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the elderly population and accounts for substantial disability and health care costs. Disability is largely driven by mobility deficits caused by impaired gait. Effective treatments are available to restore lower limb function and improve gait, but response to treatment varies greatly from patient to patient and often shows only small effect sizes. Addressing this heterogeneity requires personalization, a concept referred to precisi...